Free Trial
→ Peptide Company Lands Exclusive MMA Wellness Partnership (From The Tomorrow Investor) (Ad)tc pixel Free XPRO Stock Alerts

Expro Group (XPRO) Financials

Expro Group logo
$15.84 +0.18 (+1.13%)
As of 01:55 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare
Annual Income Statements for Expro Group

Annual Income Statements for Expro Group

This table shows Expro Group's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 79 -135 -159 -91 -65 -307 -132 -20 -23 52 52
Consolidated Net Income / (Loss)		 106 -156 -159 -91 -65 -307 -132 -20 -23 52 52
Net Income / (Loss) Continuing Operations		 106 -156 -159 -91 -65 -307 -132 -20 -23 52 52
Total Pre-Tax Income 		143 -182 -87 -94 -66 -310 -116 21 21 98 86
Total Operating Income		 144 -163 -215 -93 -72 -322 -128 2.46 11 94 81
Total Gross Profit		 460 170 110 143 133 108 125 222 271 379 384
Total Revenue		 975 488 455 522 810 675 826 1,279 1,513 1,713 1,607
Operating Revenue		 975 488 455 522 810 675 826 1,279 1,513 1,713 1,607
Total Cost of Revenue		 515 317 345 379 677 567 701 1,057 1,241 1,333 1,223
Operating Cost of Revenue		 515 317 345 379 677 567 701 1,057 1,241 1,333 1,223
Total Operating Expenses		 316 334 325 236 205 430 252 220 261 285 303
Selling, General & Admin Expense		 174 172 129 127 29 24 74 58 64 88 76
Depreciation Expense		 109 114 122 111 123 114 124 140 172 163 192
Other Operating Expenses / (Income)		 -1.53 - - - 4.44 14 7.83 7.83 14 17 29
Restructuring Charge		 35 46 75 -0.31 0.00 1.63 48 14 9.76 16 6.16
Total Other Income / (Expense), net		 -0.23 -18 128 -0.80 6.57 12 12 19 10 3.80 5.20
Interest & Investment Income		 0.34 2.07 2.31 4.24 6.34 7.93 7.95 15 8.91 3.91 2.56
Other Income / (Expense), net		 -0.57 -20 126 -5.05 0.23 3.91 3.99 3.15 1.23 -0.11 2.65
Income Tax Expense		 37 -26 73 -2.95 -1.14 -3.40 16 41 44 46 35
Basic Earnings per Share		 $0.51 ($0.77) ($0.72) ($0.41) ($0.91) ($4.33) ($1.64) ($0.18) ($0.21) $0.45 $0.45
Weighted Average Basic Shares Outstanding		 154.66M 176.58M 222.94M 224.00M 70.89M 70.89M 80.53M 109.07M 109.16M 114.76M 115.00M
Diluted Earnings per Share		 $0.50 ($0.77) ($0.72) ($0.41) ($0.91) - - ($0.18) ($0.21) $0.45 $0.45
Weighted Average Diluted Shares Outstanding		 209.15M 176.58M 222.94M 224.00M 70.89M 70.89M 80.53M 109.07M 109.16M 115.83M 115.75M
Weighted Average Basic & Diluted Shares Outstanding		 155.10M 176.58M 222.94M 224.00M 70.89M 70.89M 80.53M 108.82M 110.08M 116.38M 113.77M

Quarterly Income Statements for Expro Group

This table shows Expro Group's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -14 -12 -2.68 15 16 23 14 18 14 5.77 -1.03
Consolidated Net Income / (Loss)		 -14 -12 -2.68 15 16 23 14 18 14 5.77 -1.03
Net Income / (Loss) Continuing Operations		 -14 -12 -2.68 15 16 23 14 18 14 5.77 -1.03
Total Pre-Tax Income 		-0.58 0.96 9.61 29 27 32 12 32 29 13 5.18
Total Operating Income		 -1.57 -6.68 8.42 28 26 32 10 33 26 12 3.16
Total Gross Profit		 54 90 75 103 92 110 85 103 100 96 70
Total Revenue		 370 407 383 470 423 437 391 423 411 382 368
Operating Revenue		 370 407 383 470 423 437 391 423 411 382 368
Total Cost of Revenue		 316 317 308 367 331 327 305 320 311 287 298
Operating Cost of Revenue		 316 317 308 367 331 327 305 320 311 287 298
Total Operating Expenses		 56 97 67 75 65 78 75 70 74 84 67
Selling, General & Admin Expense		 15 19 19 26 20 23 22 14 20 19 18
Depreciation Expense		 37 63 40 41 40 42 45 47 46 54 45
Other Operating Expenses / (Income)		 1.90 8.90 5.06 -0.24 3.18 9.04 6.08 6.71 5.78 9.95 3.23
Restructuring Charge		 0.82 5.43 2.16 8.79 1.44 3.95 1.74 2.27 1.29 0.86 0.29
Total Other Income / (Expense), net		 0.99 7.64 1.19 1.52 0.61 0.48 1.91 -0.60 2.32 1.58 2.03
Interest & Investment Income		 2.12 2.86 0.71 1.19 0.35 1.66 0.26 -0.88 1.79 1.39 1.68
Other Income / (Expense), net		 -1.13 4.77 0.49 0.33 0.26 -1.19 1.65 0.28 0.52 0.19 0.35
Income Tax Expense		 13 13 12 14 10 9.38 -1.72 14 15 7.61 6.22
Basic Earnings per Share		 ($0.13) ($0.11) ($0.02) $0.13 $0.14 $0.20 $0.12 $0.16 $0.12 $0.05 ($0.01)
Weighted Average Basic Shares Outstanding		 108.78M 109.16M 110.18M 113.98M 117.47M 114.76M 116.22M 115.44M 114.80M 115.00M 113.62M
Diluted Earnings per Share		 ($0.13) ($0.11) ($0.02) $0.13 $0.14 - $0.12 $0.16 $0.12 $0.05 ($0.01)
Weighted Average Diluted Shares Outstanding		 108.78M 109.16M 110.18M 114.92M 118.29M 115.83M 116.93M 115.51M 115.45M 115.75M 113.62M
Weighted Average Basic & Diluted Shares Outstanding		 110.67M 110.08M 110.54M 121.05M 117.50M 116.38M 115.39M 115.59M 113.56M 113.77M 113.40M

Annual Cash Flow Statements for Expro Group

This table details how cash moves in and out of Expro Group's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 113 -283 -107 -27 -48 -26 119 -21 -65 31 13
Net Cash From Operating Activities		 428 -11 25 -33 81 70 16 80 138 169 210
Net Cash From Continuing Operating Activities		 428 -11 25 -33 81 70 16 80 138 169 210
Net Income / (Loss) Continuing Operations		 106 -156 -159 -91 -65 -307 -132 -20 -23 52 52
Consolidated Net Income / (Loss)		 106 -156 -159 -91 -65 -307 -132 -20 -23 52 52
Depreciation Expense		 109 114 122 111 123 114 124 140 172 163 192
Non-Cash Adjustments To Reconcile Net Income		 25 57 5.01 12 46 272 42 17 25 24 15
Changes in Operating Assets and Liabilities, net		 188 -27 57 -65 -23 -7.87 -23 -57 -35 -70 -49
Net Cash From Investing Activities		 -175 -179 -78 10 -152 -97 112 -71 -148 -165 -107
Net Cash From Continuing Investing Activities		 -175 -179 -78 10 -152 -97 112 -71 -148 -165 -107
Purchase of Property, Plant & Equipment		 -100 -42 -22 -20 -104 -112 -82 -82 -122 -144 -112
Acquisitions		 -79 -150 - - -48 0.00 190 -7.97 -29 -32 0.00
Sale of Property, Plant & Equipment		 4.58 3.86 14 7.09 0.01 16 3.82 7.28 2.01 2.90 5.00
Sale and/or Maturity of Investments		 0.00 11 53 144 - 0.00 0.00 11 0.57 0.00 0.00
Other Investing Activities, net		 0.00 -0.31 0.00 -37 - - - 0.00 0.00 7.50 0.00
Net Cash From Financing Activities		 -141 -97 -52 -7.95 22 -0.63 -7.18 -26 -49 30 -97
Net Cash From Continuing Financing Activities		 -141 -97 -52 -7.95 22 -0.63 -7.18 -26 -49 30 -97
Repayment of Debt		 -0.77 -7.20 -0.68 -7.63 -6.36 -2.90 -6.29 -0.13 -67 -46 -44
Repurchase of Common Equity		 - - - 0.00 - 0.00 0.00 -13 -20 -14 -40
Issuance of Debt		 0.15 0.36 - - - - 0.00 0.00 50 117 0.00
Other Financing Activities, net		 -4.50 -3.86 -2.90 -1.64 28 2.27 -0.88 -12 -12 -27 -13
Effect of Exchange Rate Changes		 1.15 3.68 -1.11 3.38 0.57 0.63 -1.88 - -6.03 -2.41 6.75

Quarterly Cash Flow Statements for Expro Group

This table details how cash moves in and out of Expro Group's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 76 -104 11 -29 32 18 -4.49 27 -8.87 -1.15 -27
Net Cash From Operating Activities		 59 33 30 -13 55 97 42 48 63 57 25
Net Cash From Continuing Operating Activities		 59 33 30 -13 55 97 42 48 63 57 25
Net Income / (Loss) Continuing Operations		 -14 -12 -2.68 15 16 23 14 18 14 5.77 -1.03
Consolidated Net Income / (Loss)		 -14 -12 -2.68 15 16 23 14 18 14 5.77 -1.03
Depreciation Expense		 37 63 40 41 40 42 45 47 46 54 45
Non-Cash Adjustments To Reconcile Net Income		 9.05 9.92 1.13 7.67 4.73 10 2.05 -0.42 4.30 9.48 8.93
Changes in Operating Assets and Liabilities, net		 26 -28 -8.66 -77 -6.08 22 -20 -16 -1.27 -12 -28
Net Cash From Investing Activities		 -27 -57 -31 -66 -24 -44 -33 -16 -24 -34 -26
Net Cash From Continuing Investing Activities		 -27 -57 -31 -66 -24 -44 -33 -16 -24 -34 -26
Purchase of Property, Plant & Equipment		 -27 -37 -31 -36 -32 -44 -33 -21 -24 -34 -26
Net Cash From Financing Activities		 48 -79 15 50 -2.87 -32 -15 -8.77 -48 -25 -25
Net Cash From Continuing Financing Activities		 48 -79 15 50 -2.87 -32 -15 -8.77 -48 -25 -25
Repayment of Debt		 -0.13 -66 -0.54 -45 -0.01 1.06 -0.34 -0.55 -23 -20 -0.52
Repurchase of Common Equity		 - -10 0.00 - - -14 -10 -5.01 -25 - -20
Other Financing Activities, net		 -2.20 -3.27 -5.77 -1.23 -2.86 -19 -4.74 -3.22 -0.57 -4.35 -4.88
Effect of Exchange Rate Changes		 -3.07 0.02 -2.72 0.03 3.15 - 2.22 3.88 0.33 0.33 -0.82

Annual Balance Sheets for Expro Group

This table presents Expro Group's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 1,727 1,588 1,262 1,194 994 1,040 1,855 1,937 2,013 2,334 2,259
Total Current Assets		 1,024 640 512 492 466 428 764 866 852 964 960
Cash & Equivalents		 602 320 213 186 195 117 235 215 152 183 196
Restricted Cash		 - - - 0.00 1.36 3.79 4.46 3.67 1.43 1.63 1.38
Accounts Receivable		 246 167 127 189 167 194 319 419 469 518 477
Inventories, net		 161 139 76 69 79 53 125 154 143 159 168
Current Deferred & Refundable Income Taxes		 - - - - - 20 21 27 28 29 32
Other Current Assets		 14 14 14 20 24 40 59 47 58 74 86
Plant, Property, & Equipment, net		 625 567 470 416 328 295 479 462 513 564 523
Total Noncurrent Assets		 78 381 280 285 199 317 612 609 648 806 776
Long-Term Investments		 - - - - - 45 58 66 66 73 79
Noncurrent Note & Lease Receivables		 - - - - - 11 12 9.69 9.77 7.43 7.43
Goodwill		 25 211 211 211 100 26 180 221 248 349 349
Intangible Assets		 - 45 34 31 17 173 253 230 240 299 251
Employee Benefit Assets		 - - - - - - - - - - 0.00
Other Noncurrent Operating Assets		 53 46 35 29 66 62 110 83 85 78 90
Total Liabilities & Shareholders' Equity		 1,727 1,588 1,262 1,194 994 1,040 1,855 1,937 2,013 2,334 2,259
Total Liabilities		 275 277 146 159 184 428 557 651 717 842 725
Total Current Liabilities		 190 99 118 130 129 224 331 438 489 484 444
Accounts Payable		 13 16 109 124 120 136 213 273 326 340 269
Current Deferred & Payable Income Tax Liabilities		 - - - - - 14 23 37 45 52 51
Other Current Liabilities		 - - - - 7.93 74 95 128 118 92 124
Total Noncurrent Liabilities		 85 177 28 29 55 204 226 214 228 358 282
Long-Term Debt		 - - - - - - - 0.00 20 121 79
Noncurrent Deferred & Payable Income Tax Liabilities		 40 21 0.23 0.22 2.92 27 32 88 82 119 97
Noncurrent Employee Benefit Liabilities		 - - - - - 58 29 11 10 10 0.31
Other Noncurrent Operating Liabilities		 45 156 27 29 52 119 165 114 116 107 105
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 1,451 1,311 1,116 1,035 810 612 1,298 1,286 1,296 1,491 1,534
Total Preferred & Common Equity		 1,211 1,311 1,116 1,035 810 612 1,298 1,286 1,296 1,491 1,534
Total Common Equity		 1,211 1,311 1,116 1,035 810 612 1,298 1,286 1,296 1,491 1,534
Common Stock		 715 1,040 1,054 1,066 1,079 1,007 1,836 1,855 1,917 2,088 2,119
Retained Earnings		 532 317 107 17 -221 -404 -536 -556 -579 -527 -476
Treasury Stock		 -9.30 -13 -14 -15 -17 0.00 -23 -41 -65 -83 -127
Accumulated Other Comprehensive Income / (Loss)		 -26 -33 -31 -32 -30 -1.49 20 28 22 14 18

Quarterly Balance Sheets for Expro Group

This table presents Expro Group's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 1,854 1,936 1,933 1,977 2,000 2,317 2,344 2,293 2,338 2,305 2,245
Total Current Assets		 791 854 858 911 862 951 984 949 1,002 982 964
Cash & Equivalents		 154 185 179 255 163 133 166 179 207 198 171
Restricted Cash		 3.03 1.43 1.96 1.69 1.31 1.99 1.32 0.86 0.66 0.74 0.04
Accounts Receivable		 421 425 436 413 439 534 532 483 505 493 492
Inventories, net		 136 156 155 154 164 171 179 164 168 172 168
Current Deferred & Refundable Income Taxes		 24 27 27 27 29 30 33 34 37 35 40
Other Current Assets		 52 59 60 60 66 80 73 88 85 84 93
Plant, Property, & Equipment, net		 449 462 465 467 500 536 536 554 540 534 510
Total Noncurrent Assets		 615 621 610 599 638 830 823 791 796 790 771
Long-Term Investments		 65 68 68 68 71 75 76 77 80 81 77
Noncurrent Note & Lease Receivables		 10 9.18 11 10 9.18 8.59 8.01 7.43 7.43 7.43 7.43
Goodwill		 221 228 228 229 248 343 344 344 349 349 349
Intangible Assets		 236 232 222 213 230 321 308 286 273 261 240
Employee Benefit Assets		 - - - - - - - - - - 1.50
Other Noncurrent Operating Assets		 83 83 81 79 80 83 87 76 87 92 96
Total Liabilities & Shareholders' Equity		 1,854 1,936 1,933 1,977 2,000 2,317 2,344 2,293 2,338 2,305 2,245
Total Liabilities		 592 666 647 700 706 857 860 793 818 788 729
Total Current Liabilities		 382 453 441 447 466 500 497 451 468 464 453
Accounts Payable		 240 272 298 297 299 334 327 298 317 299 273
Current Deferred & Payable Income Tax Liabilities		 41 41 42 43 48 52 53 51 49 50 57
Other Current Liabilities		 101 139 101 107 119 114 118 101 103 115 122
Total Noncurrent Liabilities		 210 213 207 253 240 358 363 343 350 324 277
Long-Term Debt		 - - - 50 40 121 121 121 121 99 79
Noncurrent Deferred & Payable Income Tax Liabilities		 29 28 26 25 81 116 117 103 102 102 90
Noncurrent Employee Benefit Liabilities		 20 11 10 9.16 8.70 7.07 5.68 9.81 7.80 5.82 0.00
Other Noncurrent Operating Liabilities		 162 175 170 168 110 113 119 109 119 116 108
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 1,262 1,271 1,286 1,277 1,294 1,459 1,483 1,500 1,520 1,517 1,515
Total Preferred & Common Equity		 1,262 1,271 1,286 1,277 1,294 1,459 1,483 1,500 1,520 1,517 1,515
Total Common Equity		 1,262 1,271 1,286 1,277 1,294 1,459 1,483 1,500 1,520 1,517 1,515
Common Stock		 1,852 1,860 1,865 1,871 1,922 2,073 2,081 2,095 2,103 2,111 2,110
Retained Earnings		 -569 -562 -553 -567 -582 -567 -550 -513 -495 -481 -477
Treasury Stock		 -41 -54 -54 -55 -69 -69 -69 -97 -102 -127 -136
Accumulated Other Comprehensive Income / (Loss)		 20 27 27 27 22 22 22 14 14 14 18

Annual Metrics And Ratios for Expro Group

This table displays calculated financial ratios and metrics derived from Expro Group's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -15.45% -49.98% -6.71% 14.89% 55.04% -16.67% 22.33% 54.94% 18.24% 13.22% -6.17%
EBITDA Growth		 -36.13% -127.52% 148.29% -59.95% 274.45% -507.20% 102.67% 2,564.57% 26.77% 39.74% 7.13%
EBIT Growth		 -53.03% -228.45% 51.66% -10.22% 26.23% -340.74% 61.19% 104.54% 114.49% 681.43% -10.93%
NOPAT Growth		 -55.16% -207.60% -31.45% 56.75% 21.98% -344.76% 60.42% 97.37% -412.37% 514.23% -2.67%
Net Income Growth		 -53.73% -247.09% -2.16% 43.10% 28.62% -374.12% 57.05% 84.73% -15.96% 322.25% -0.45%
EPS Growth		 -51.46% -254.00% 6.49% 43.06% 28.62% 0.00% 0.00% 0.00% -16.67% 314.29% 0.00%
Operating Cash Flow Growth		 15.97% -102.53% 328.73% -231.77% 348.77% -13.32% -77.07% 396.59% 72.52% 22.54% 24.01%
Free Cash Flow Firm Growth		 28.04% -206.84% 106.08% -535.35% 347.38% -135.66% -1,004.58% 99.44% -2,847.81% -95.10% 131.84%
Invested Capital Growth		 -12.91% 15.75% -16.68% 0.12% -25.86% -27.28% 124.15% 0.13% 9.48% 23.59% -1.32%
Revenue Q/Q Growth		 -10.64% -16.31% 2.33% 5.56% 38.16% 1.72% -9.37% 4.52% 3.83% 1.79% -3.29%
EBITDA Q/Q Growth		 -19.07% -493.49% -48.69% 118.05% 63.70% -202.68% 107.76% 189.66% 2.18% 4.91% -2.57%
EBIT Q/Q Growth		 -30.90% -93.43% -54.23% 47.89% -7.19% -84.64% 41.40% 105.66% -66.97% 53.17% -18.30%
NOPAT Q/Q Growth		 -35.71% -73.28% -28.95% 48.79% -6.23% -89.48% 41.93% 96.75% -801.76% 262.86% -26.70%
Net Income Q/Q Growth		 -29.64% -87.76% -36.87% 50.68% 22.10% -110.97% 33.96% 83.79% -1,274.46% 215.30% -25.04%
EPS Q/Q Growth		 -26.47% -108.11% -22.03% 50.60% 22.10% 0.00% 0.00% 84.21% -1,150.00% 221.43% -25.00%
Operating Cash Flow Q/Q Growth		 9.59% -106.76% 275.80% 7.27% 622.82% -28.20% -64.54% 2,649.28% -30.31% 61.63% -16.10%
Free Cash Flow Firm Q/Q Growth		 23.79% -242.13% 104.63% -17,636.35% 654.04% -128.45% -497.95% 99.48% -368.01% 39.63% -27.74%
Invested Capital Q/Q Growth		 -10.70% 38.09% -11.08% 3.06% -21.82% -3.22% 141.10% -3.77% 9.36% -0.51% 0.06%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 47.20% 34.92% 24.16% 27.45% 16.40% 16.02% 15.09% 17.36% 17.95% 22.15% 23.89%
EBITDA Margin		 25.88% -14.24% 7.37% 2.57% 6.21% -30.32% 0.66% 11.36% 12.18% 15.04% 17.17%
Operating Margin		 14.74% -33.51% -47.22% -17.78% -8.95% -47.74% -15.45% 0.19% 0.71% 5.50% 5.05%
EBIT Margin		 14.68% -37.70% -19.54% -18.74% -8.92% -47.17% -14.97% 0.44% 0.80% 5.49% 5.21%
Profit (Net Income) Margin		 10.89% -32.01% -35.06% -17.37% -7.99% -45.49% -15.97% -1.57% -1.54% 3.03% 3.22%
Tax Burden Percent		 73.98% 85.89% 184.26% 96.85% 98.27% 98.90% 114.07% -95.46% -111.52% 53.00% 59.86%
Interest Burden Percent		 100.24% 98.87% 97.40% 95.67% 91.22% 97.51% 93.57% 376.02% 174.02% 104.15% 103.05%
Effective Tax Rate		 26.02% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 195.46% 211.52% 47.00% 40.14%
Return on Invested Capital (ROIC)		 11.54% -12.37% -16.53% -7.86% -7.04% -42.58% -12.35% -0.24% -1.15% 4.07% 3.61%
ROIC Less NNEP Spread (ROIC-NNEP)		 11.57% -3.24% -13.53% 2.50% -0.09% 2.35% 6.04% 5.88% 3.53% 2.87% 1.74%
Return on Net Nonoperating Assets (RNNOA)		 -4.29% 1.07% 3.39% -0.58% 0.02% -0.60% -1.47% -1.32% -0.66% -0.35% -0.19%
Return on Equity (ROE)		 7.25% -11.30% -13.14% -8.44% -7.02% -43.18% -13.81% -1.56% -1.81% 3.73% 3.42%
Cash Return on Invested Capital (CROIC)		 25.35% -26.97% 1.67% -7.98% 22.66% -10.99% -88.95% -0.36% -10.20% -17.03% 4.94%
Operating Return on Assets (OROA)		 8.21% -11.09% -6.24% -7.98% -6.60% -31.31% -8.54% 0.30% 0.61% 4.33% 3.65%
Return on Assets (ROA)		 6.09% -9.42% -11.19% -7.39% -5.92% -30.19% -9.11% -1.06% -1.18% 2.39% 2.25%
Return on Common Equity (ROCE)		 6.01% -10.31% -13.14% -8.44% -7.02% -43.18% -13.81% -1.56% -1.81% 3.73% 3.42%
Return on Equity Simple (ROE_SIMPLE)		 8.76% -11.90% -14.29% -8.77% -7.99% -50.17% -10.16% -1.57% -1.80% 3.48% 0.00%
Net Operating Profit after Tax (NOPAT)		 106 -114 -150 -65 -51 -226 -89 -2.35 -12 50 49
NOPAT Margin		 10.90% -23.46% -33.05% -12.44% -6.26% -33.42% -10.81% -0.18% -0.80% 2.91% 3.02%
Net Nonoperating Expense Percent (NNEP)		 -0.03% -9.13% -3.00% -10.36% -6.95% -44.93% -18.39% -6.12% -4.67% 1.20% 1.87%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - -0.18% -0.92% 3.09% 3.01%
Cost of Revenue to Revenue		 52.80% 65.08% 75.84% 72.55% 83.60% 83.98% 84.91% 82.64% 82.05% 77.85% 76.11%
SG&A Expenses to Revenue		 17.90% 35.26% 28.41% 24.24% 3.62% 3.53% 8.95% 4.56% 4.25% 5.16% 4.73%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 32.46% 68.43% 71.38% 45.23% 25.35% 63.77% 30.54% 17.16% 17.23% 16.66% 18.84%
Earnings before Interest and Taxes (EBIT)		 143 -184 -89 -98 -72 -318 -124 5.61 12 94 84
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 252 -69 34 13 50 -205 5.46 145 184 258 276
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.01 2.03 1.33 1.13 1.44 1.01 1.21 1.53 1.36 0.98 0.99
Price to Tangible Book Value (P/TBV)		 2.05 2.52 1.70 1.48 1.68 1.50 1.81 2.36 2.18 1.74 1.62
Price to Revenue (P/Rev)		 2.50 5.46 3.26 2.24 1.44 0.92 1.90 1.54 1.16 0.86 0.94
Price to Earnings (P/E)		 30.80 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 28.22 29.33
Dividend Yield		 3.82% 3.76% 4.51% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 3.25% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 3.54% 3.41%
Enterprise Value to Invested Capital (EV/IC)		 2.43 2.36 1.44 1.16 1.58 1.02 1.27 1.68 1.43 0.98 0.99
Enterprise Value to Revenue (EV/Rev)		 2.14 4.80 2.63 1.84 1.20 0.67 1.54 1.32 1.03 0.78 0.82
Enterprise Value to EBITDA (EV/EBITDA)		 8.26 0.00 35.63 71.76 19.28 0.00 232.45 11.60 8.48 5.16 4.78
Enterprise Value to EBIT (EV/EBIT)		 14.56 0.00 0.00 0.00 0.00 0.00 0.00 300.61 129.79 14.12 15.74
Enterprise Value to NOPAT (EV/NOPAT)		 19.60 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 26.62 27.15
Enterprise Value to Operating Cash Flow (EV/OCF)		 4.87 0.00 48.21 0.00 11.93 6.45 78.56 21.04 11.30 7.84 6.28
Enterprise Value to Free Cash Flow (EV/FCFF)		 8.92 0.00 78.76 0.00 5.93 0.00 0.00 0.00 0.00 0.00 19.85
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.01 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.02 0.08 0.05
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.08 0.05
Financial Leverage		 -0.37 -0.33 -0.25 -0.23 -0.22 -0.25 -0.24 -0.23 -0.19 -0.12 -0.11
Leverage Ratio		 1.19 1.20 1.17 1.14 1.19 1.43 1.52 1.47 1.53 1.56 1.52
Compound Leverage Factor		 1.19 1.19 1.14 1.09 1.08 1.39 1.42 5.52 2.66 1.62 1.56
Debt to Total Capital		 0.50% 0.02% 0.42% 0.54% 0.00% 0.00% 0.00% 0.00% 1.52% 7.51% 4.90%
Short-Term Debt to Total Capital		 0.50% 0.02% 0.42% 0.54% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.52% 7.51% 4.90%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 16.50% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 83.00% 99.98% 99.58% 99.46% 100.00% 100.00% 100.00% 100.00% 98.48% 92.49% 95.10%
Debt to EBITDA		 0.03 0.00 0.14 0.42 0.00 0.00 0.00 0.00 0.11 0.47 0.29
Net Debt to EBITDA		 -2.36 4.60 -8.63 -15.43 0.00 0.00 0.00 0.00 -1.08 -0.53 -0.71
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.11 0.47 0.29
Debt to NOPAT		 0.07 0.00 -0.03 -0.09 0.00 0.00 0.00 0.00 -1.66 2.43 1.63
Net Debt to NOPAT		 -5.60 2.79 1.92 3.19 0.00 0.00 0.00 0.00 16.57 -2.74 -4.06
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -1.66 2.43 1.63
Altman Z-Score		 7.17 6.38 6.72 4.96 4.48 0.20 1.79 2.35 2.06 1.84 2.07
Noncontrolling Interest Sharing Ratio		 17.16% 8.71% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 5.40 6.44 4.33 3.79 3.62 1.91 2.31 1.98 1.74 1.99 2.16
Quick Ratio		 4.47 4.90 3.56 3.10 2.81 1.38 1.67 1.45 1.27 1.45 1.52
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 233 -249 15 -66 163 -58 -643 -3.63 -107 -209 66
Operating Cash Flow to CapEx		 449.59% -28.30% 311.23% -258.16% 78.05% 72.74% 20.78% 107.43% 115.16% 120.47% 195.71%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.56 0.29 0.32 0.43 0.74 0.66 0.57 0.67 0.77 0.79 0.70
Accounts Receivable Turnover		 3.06 2.36 3.09 3.30 4.55 3.75 3.22 3.46 3.41 3.47 3.23
Inventory Turnover		 2.82 2.11 3.20 5.20 9.14 8.58 7.86 7.58 8.36 8.82 7.48
Fixed Asset Turnover		 1.62 0.82 0.88 1.18 2.17 2.17 2.14 2.72 3.10 3.18 2.96
Accounts Payable Turnover		 35.15 21.98 5.52 3.26 5.54 4.42 4.01 4.35 4.15 4.00 4.02
Days Sales Outstanding (DSO)		 119.31 154.83 118.23 110.59 80.23 97.41 113.35 105.35 107.17 105.13 112.95
Days Inventory Outstanding (DIO)		 129.54 172.76 114.03 70.20 39.94 42.56 46.45 48.13 43.67 41.39 48.78
Days Payable Outstanding (DPO)		 10.38 16.60 66.12 112.11 65.84 82.60 90.94 83.86 88.04 91.21 90.85
Cash Conversion Cycle (CCC)		 238.47 310.99 166.13 68.68 54.33 57.37 68.86 69.61 62.80 55.30 70.88
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 857 992 827 828 614 446 1,000 1,001 1,096 1,355 1,337
Invested Capital Turnover		 1.06 0.53 0.50 0.63 1.12 1.27 1.14 1.28 1.44 1.40 1.19
Increase / (Decrease) in Invested Capital		 -127 135 -165 1.00 -214 -167 554 1.28 95 259 -18
Enterprise Value (EV)		 2,083 2,342 1,194 963 969 454 1,268 1,687 1,562 1,329 1,319
Market Capitalization		 2,437 2,662 1,484 1,171 1,166 620 1,566 1,972 1,762 1,465 1,516
Book Value per Share		 $7.81 $5.90 $5.00 $4.61 $3.59 $2.70 $11.89 $11.83 $11.71 $12.69 $13.51
Tangible Book Value per Share		 $7.65 $4.74 $3.90 $3.53 $3.07 $1.83 $7.92 $7.68 $7.31 $7.18 $8.23
Total Capital		 1,459 1,312 1,121 1,040 810 612 1,298 1,286 1,316 1,613 1,613
Total Debt		 7.32 0.28 4.72 5.63 0.00 0.00 0.00 0.00 20 121 79
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 20 121 79
Net Debt		 -595 -319 -289 -207 -197 -166 -297 -284 -200 -137 -197
Capital Expenditures (CapEx)		 95 38 7.96 13 104 97 78 75 120 141 107
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 239 221 104 155 141 83 193 209 210 295 319
Debt-free Net Working Capital (DFNWC)		 841 541 398 368 338 204 433 428 363 480 517
Net Working Capital (NWC)		 834 541 394 362 338 204 433 428 363 480 517
Net Nonoperating Expense (NNE)		 0.17 42 9.14 26 14 81 43 18 11 -2.01 -3.11
Net Nonoperating Obligations (NNO)		 -595 -319 -289 -207 -197 -166 -297 -284 -200 -137 -197
Total Depreciation and Amortization (D&A)		 109 114 122 111 123 114 129 140 172 163 192
Debt-free, Cash-free Net Working Capital to Revenue		 24.53% 45.42% 22.93% 29.70% 17.38% 12.30% 23.38% 16.36% 13.85% 17.22% 19.86%
Debt-free Net Working Capital to Revenue		 86.34% 110.96% 87.58% 70.43% 41.67% 30.18% 52.43% 33.44% 23.98% 28.00% 32.15%
Net Working Capital to Revenue		 85.58% 110.90% 86.54% 69.35% 41.67% 30.18% 52.43% 33.44% 23.98% 28.00% 32.15%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $3.06 ($4.62) ($4.32) ($2.46) ($6.30) ($4.14) ($1.64) ($0.18) ($0.21) $0.45 $0.45
Adjusted Weighted Average Basic Shares Outstanding		 25.78M 29.43M 37.16M 37.41M 37.61M 37.76M 109.38M 109.07M 109.16M 114.76M 115.00M
Adjusted Diluted Earnings per Share		 $3.00 ($4.62) ($4.32) ($2.46) ($6.30) ($4.14) ($1.64) $0.00 $0.00 $0.45 $0.45
Adjusted Weighted Average Diluted Shares Outstanding		 34.86M 29.43M 37.16M 37.41M 37.61M 37.76M 109.38M 108.82M 110.08M 115.83M 115.75M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 ($2.46) ($6.30) ($4.14) ($1.64) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 25.89M 37.08M 37.23M 37.33M 37.53M 37.67M 80.53M 108.82M 110.08M 116.38M 113.77M
Normalized Net Operating Profit after Tax (NOPAT)		 132 -81 -99 -66 -16 -30 -57 11 14 59 52
Normalized NOPAT Margin		 13.52% -16.63% -21.77% -12.66% -2.02% -4.49% -6.86% 0.88% 0.95% 3.42% 3.25%
Pre Tax Income Margin		 14.72% -37.27% -19.03% -17.93% -8.13% -45.99% -14.00% 1.65% 1.38% 5.72% 5.37%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 128.53% -55.77% -31.45% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 128.53% -55.77% -31.45% 0.00% 0.00% 0.00% 0.00% -64.51% -85.72% 27.26% 77.56%

Quarterly Metrics And Ratios for Expro Group

This table displays calculated financial ratios and metrics derived from Expro Group's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 - - - - - - - - - - 113,765,561.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 113,765,561.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - -0.01
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 10.61% 15.89% 13.03% 18.32% 14.33% 7.40% 1.93% -9.99% -2.71% -12.53% -5.96%
EBITDA Growth		 25.66% 6.88% 51.71% 22.03% 92.35% 19.78% 17.02% 15.85% 9.59% -9.96% -14.81%
EBIT Growth		 62.49% -108.46% 470.42% 47.18% 1,076.64% 1,714.81% 34.50% 17.18% 2.27% -61.02% -70.75%
NOPAT Growth		 79.41% 683.99% -130.27% 65.96% 1,545.36% -73.78% 601.91% 26.60% -19.27% -77.57% -105.35%
Net Income Growth		 21.08% -196.03% 57.85% 64.45% 217.20% 285.49% 621.03% 17.77% -14.21% -74.94% -107.41%
EPS Growth		 0.00% -191.67% 0.00% 62.50% 207.69% 0.00% 700.00% 23.08% -14.29% -75.00% -108.33%
Operating Cash Flow Growth		 8,922.64% -64.73% 40.40% -151.95% -6.01% 197.13% 38.65% 467.52% 14.22% -41.41% -39.09%
Free Cash Flow Firm Growth		 105.88% -185.46% -1,340.02% -570.88% -1,026.09% -2,726.55% -198.43% 110.61% 111.21% 109.73% 106.60%
Invested Capital Growth		 -3.67% 9.48% 8.13% 32.09% 35.85% 23.59% 24.15% -1.13% -1.88% -1.32% -1.27%
Revenue Q/Q Growth		 -6.83% 9.99% -5.72% 22.47% -9.97% 3.31% -10.52% 8.15% -2.69% -7.11% -3.81%
EBITDA Q/Q Growth		 -38.32% 75.64% -19.55% 40.01% -2.78% 9.38% -21.40% 38.61% -8.03% -10.13% -25.64%
EBIT Q/Q Growth		 -114.18% 29.51% 567.70% 214.78% -5.89% 16.55% -61.05% 174.24% -17.87% -55.58% -70.77%
NOPAT Q/Q Growth		 -112.60% 7,966.51% -102.71% 717.79% 9.77% 42.69% -48.13% 55.83% -30.00% -60.36% -112.37%
Net Income Q/Q Growth		 -249.39% 10.57% 78.44% 671.01% 6.47% 41.53% -39.45% 29.07% -22.44% -58.66% -117.91%
EPS Q/Q Growth		 -262.50% 15.38% 0.00% 0.00% 7.69% 0.00% 0.00% 33.33% -25.00% -58.33% -120.00%
Operating Cash Flow Q/Q Growth		 132.06% -44.29% -8.67% -144.00% 519.90% 76.09% -57.38% 16.63% 30.50% -9.67% -55.70%
Free Cash Flow Firm Q/Q Growth		 -45.12% -122.50% -918.20% -274.51% -7.94% 31.33% -7.50% 113.32% 14.05% -40.39% -27.07%
Invested Capital Q/Q Growth		 -3.30% 9.36% 0.21% 24.65% -0.55% -0.51% 0.67% -0.73% -1.31% 0.06% 0.71%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 14.60% 22.10% 19.56% 21.96% 21.66% 25.12% 21.84% 24.31% 24.36% 25.01% 19.03%
EBITDA Margin		 9.39% 14.99% 12.79% 14.62% 15.79% 16.72% 14.68% 18.82% 17.79% 17.21% 13.30%
Operating Margin		 -0.43% -1.64% 2.20% 5.90% 6.18% 7.31% 2.64% 7.70% 6.43% 3.09% 0.86%
EBIT Margin		 -0.73% -0.47% 2.32% 5.97% 6.24% 7.04% 3.06% 7.77% 6.56% 3.14% 0.95%
Profit (Net Income) Margin		 -3.75% -3.05% -0.70% 3.25% 3.85% 5.27% 3.57% 4.26% 3.39% 1.51% -0.28%
Tax Burden Percent		 2,398.27% -1,296.24% -27.85% 52.31% 60.90% 71.07% 114.03% 56.33% 48.54% 43.15% -19.95%
Interest Burden Percent		 21.44% -50.32% 107.93% 104.25% 101.31% 105.41% 102.13% 97.31% 106.64% 111.62% 147.96%
Effective Tax Rate		 0.00% 1,396.24% 127.85% 47.69% 39.10% 28.93% -14.03% 43.67% 51.46% 56.85% 119.95%
Return on Invested Capital (ROIC)		 -0.42% 30.69% -0.90% 4.18% 5.35% 7.26% 4.21% 5.33% 3.84% 1.59% -0.20%
ROIC Less NNEP Spread (ROIC-NNEP)		 4.73% 71.59% -0.75% 3.71% 5.17% 7.06% 2.89% 5.60% 3.10% 1.18% 0.07%
Return on Net Nonoperating Assets (RNNOA)		 -0.92% -13.42% 0.13% -0.46% -0.74% -0.85% -0.34% -0.48% -0.31% -0.13% -0.01%
Return on Equity (ROE)		 -1.35% 17.27% -0.77% 3.72% 4.61% 6.41% 3.86% 4.85% 3.53% 1.46% -0.21%
Cash Return on Invested Capital (CROIC)		 3.91% -10.20% -9.02% -28.46% -29.24% -17.03% -16.23% 6.24% 6.82% 4.94% 3.81%
Operating Return on Assets (OROA)		 -0.56% -0.36% 1.84% 4.58% 4.86% 5.55% 2.46% 5.59% 4.69% 2.19% 0.67%
Return on Assets (ROA)		 -2.86% -2.34% -0.55% 2.50% 3.00% 4.16% 2.86% 3.06% 2.43% 1.06% -0.20%
Return on Common Equity (ROCE)		 -1.35% 17.27% -0.77% 3.72% 4.61% 6.41% 3.86% 4.85% 3.53% 1.46% -0.21%
Return on Equity Simple (ROE_SIMPLE)		 0.16% 0.00% -1.52% -0.94% 1.11% 0.00% 4.57% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -1.10 87 -2.35 14 16 23 12 18 13 5.09 -0.63
NOPAT Margin		 -0.30% 21.28% -0.61% 3.09% 3.76% 5.20% 3.01% 4.34% 3.12% 1.33% -0.17%
Net Nonoperating Expense Percent (NNEP)		 -5.16% -40.90% -0.15% 0.47% 0.19% 0.20% 1.31% -0.27% 0.74% 0.41% -0.27%
Return On Investment Capital (ROIC_SIMPLE)		 - 6.58% - - - 1.41% 0.73% 1.12% 0.79% 0.32% -0.04%
Cost of Revenue to Revenue		 85.40% 77.90% 80.44% 78.04% 78.34% 74.88% 78.16% 75.69% 75.64% 74.99% 80.97%
SG&A Expenses to Revenue		 4.17% 4.76% 5.01% 5.58% 4.84% 5.15% 5.58% 3.43% 4.98% 5.02% 4.87%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 15.03% 23.74% 17.36% 16.06% 15.49% 17.81% 19.20% 16.60% 17.93% 21.92% 18.17%
Earnings before Interest and Taxes (EBIT)		 -2.70 -1.90 8.91 28 26 31 12 33 27 12 3.50
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 35 61 49 69 67 73 57 80 73 66 49
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.98 1.36 1.71 1.74 1.40 0.98 0.77 0.65 0.91 0.99 1.31
Price to Tangible Book Value (P/TBV)		 3.03 2.18 2.71 3.18 2.50 1.74 1.33 1.10 1.51 1.62 2.14
Price to Revenue (P/Rev)		 1.73 1.16 1.42 1.55 1.24 0.86 0.67 0.59 0.83 0.94 1.25
Price to Earnings (P/E)		 1,270.11 0.00 0.00 0.00 126.23 28.22 16.88 13.91 19.92 29.33 53.96
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.08% 0.00% 0.00% 0.00% 0.79% 3.54% 5.93% 7.19% 5.02% 3.41% 1.85%
Enterprise Value to Invested Capital (EV/IC)		 2.25 1.43 1.83 1.78 1.44 0.98 0.75 0.61 0.89 0.99 1.35
Enterprise Value to Revenue (EV/Rev)		 1.55 1.03 1.29 1.50 1.16 0.78 0.59 0.49 0.72 0.82 1.14
Enterprise Value to EBITDA (EV/EBITDA)		 12.48 8.48 10.02 11.45 7.97 5.16 3.84 2.98 4.21 4.78 6.78
Enterprise Value to EBIT (EV/EBIT)		 61.78 129.79 86.29 75.58 31.87 14.12 10.51 8.09 11.63 15.74 24.06
Enterprise Value to NOPAT (EV/NOPAT)		 1,311.62 0.00 0.00 0.00 142.30 26.62 15.60 11.85 17.99 27.15 52.91
Enterprise Value to Operating Cash Flow (EV/OCF)		 11.35 11.30 13.71 22.54 18.66 7.84 5.64 3.40 4.76 6.28 9.34
Enterprise Value to Free Cash Flow (EV/FCFF)		 56.42 0.00 0.00 0.00 0.00 0.00 0.00 9.70 12.97 19.85 35.10
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.04 0.02 0.03 0.08 0.08 0.08 0.08 0.08 0.07 0.05 0.05
Long-Term Debt to Equity		 0.04 0.02 0.03 0.08 0.08 0.08 0.08 0.08 0.07 0.05 0.05
Financial Leverage		 -0.20 -0.19 -0.18 -0.12 -0.14 -0.12 -0.12 -0.09 -0.10 -0.11 -0.10
Leverage Ratio		 1.51 1.53 1.53 1.55 1.57 1.56 1.54 1.56 1.55 1.52 1.51
Compound Leverage Factor		 0.32 -0.77 1.66 1.61 1.59 1.64 1.57 1.52 1.65 1.69 2.23
Debt to Total Capital		 3.77% 1.52% 3.00% 7.66% 7.55% 7.51% 7.47% 7.38% 6.13% 4.90% 4.96%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 3.77% 1.52% 3.00% 7.66% 7.55% 7.51% 7.47% 7.38% 6.13% 4.90% 4.96%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 96.23% 98.48% 97.00% 92.34% 92.45% 92.49% 92.53% 92.62% 93.87% 95.10% 95.04%
Debt to EBITDA		 0.28 0.11 0.20 0.57 0.49 0.47 0.46 0.44 0.35 0.29 0.30
Net Debt to EBITDA		 -1.52 -1.08 -0.97 -0.42 -0.49 -0.53 -0.51 -0.60 -0.64 -0.71 -0.63
Long-Term Debt to EBITDA		 0.28 0.11 0.20 0.57 0.49 0.47 0.46 0.44 0.35 0.29 0.30
Debt to NOPAT		 29.12 -1.66 -3.13 -12.44 8.80 2.43 1.85 1.74 1.49 1.63 2.31
Net Debt to NOPAT		 -159.90 16.57 15.29 9.23 -8.83 -2.74 -2.07 -2.39 -2.73 -4.06 -4.93
Long-Term Debt to NOPAT		 29.12 -1.66 -3.13 -12.44 8.80 2.43 1.85 1.74 1.49 1.63 2.31
Altman Z-Score		 2.78 2.04 2.50 2.41 2.13 1.75 1.59 1.47 1.78 1.96 2.32
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.04 1.74 1.85 1.90 1.98 1.99 2.11 2.14 2.11 2.16 2.13
Quick Ratio		 1.49 1.27 1.29 1.33 1.40 1.45 1.47 1.52 1.49 1.52 1.46
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 37 -8.34 -85 -318 -343 -236 -254 34 39 23 17
Operating Cash Flow to CapEx		 220.77% 87.45% 97.39% -36.22% 172.58% 219.28% 125.36% 228.32% 261.11% 168.48% 98.14%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.76 0.77 0.79 0.77 0.78 0.79 0.80 0.72 0.71 0.70 0.70
Accounts Receivable Turnover		 3.49 3.41 3.60 3.36 3.56 3.47 3.73 3.22 3.24 3.23 3.25
Inventory Turnover		 8.28 8.36 7.86 8.00 7.93 8.82 8.10 7.56 7.20 7.48 7.32
Fixed Asset Turnover		 3.18 3.10 3.23 3.26 3.36 3.18 3.26 3.11 3.11 2.96 2.98
Accounts Payable Turnover		 4.47 4.15 4.41 4.13 4.24 4.00 4.45 3.94 4.04 4.02 4.25
Days Sales Outstanding (DSO)		 104.47 107.17 101.31 108.55 102.50 105.13 97.81 113.30 112.62 112.95 112.37
Days Inventory Outstanding (DIO)		 44.06 43.67 46.43 45.61 46.05 41.39 45.05 48.27 50.70 48.78 49.88
Days Payable Outstanding (DPO)		 81.65 88.04 82.73 88.31 86.08 91.21 81.96 92.58 90.39 90.85 85.87
Cash Conversion Cycle (CCC)		 66.89 62.80 65.01 65.86 62.46 55.30 60.90 69.00 72.93 70.88 76.38
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 1,002 1,096 1,099 1,369 1,362 1,355 1,364 1,354 1,336 1,337 1,347
Invested Capital Turnover		 1.43 1.44 1.47 1.35 1.42 1.40 1.40 1.23 1.23 1.19 1.17
Increase / (Decrease) in Invested Capital		 -38 95 83 333 359 259 265 -15 -26 -18 -17
Enterprise Value (EV)		 2,252 1,562 2,015 2,444 1,957 1,329 1,021 825 1,192 1,319 1,812
Market Capitalization		 2,526 1,762 2,210 2,534 2,078 1,465 1,157 991 1,373 1,516 1,981
Book Value per Share		 $11.74 $11.71 $11.75 $13.20 $12.63 $12.69 $12.89 $13.17 $13.12 $13.51 $13.32
Tangible Book Value per Share		 $7.67 $7.31 $7.41 $7.20 $7.07 $7.18 $7.47 $7.78 $7.85 $8.23 $8.14
Total Capital		 1,327 1,316 1,334 1,580 1,604 1,613 1,621 1,641 1,616 1,613 1,594
Total Debt		 50 20 40 121 121 121 121 121 99 79 79
Total Long-Term Debt		 50 20 40 121 121 121 121 121 99 79 79
Net Debt		 -275 -200 -196 -90 -121 -137 -136 -166 -181 -197 -169
Capital Expenditures (CapEx)		 27 37 31 36 32 44 33 21 24 34 26
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 206 210 232 315 320 295 318 326 319 319 341
Debt-free Net Working Capital (DFNWC)		 463 363 397 451 487 480 498 534 518 517 512
Net Working Capital (NWC)		 463 363 397 451 487 480 498 534 518 517 512
Net Nonoperating Expense (NNE)		 13 99 0.33 -0.80 -0.37 -0.34 -2.18 0.34 -1.12 -0.68 0.40
Net Nonoperating Obligations (NNO)		 -275 -200 -196 -90 -121 -137 -136 -166 -181 -197 -169
Total Depreciation and Amortization (D&A)		 37 63 40 41 40 42 45 47 46 54 45
Debt-free, Cash-free Net Working Capital to Revenue		 14.17% 13.85% 14.91% 19.35% 19.01% 17.22% 18.47% 19.50% 19.19% 19.86% 21.52%
Debt-free Net Working Capital to Revenue		 31.81% 23.98% 25.47% 27.66% 28.93% 28.00% 28.95% 31.90% 31.14% 32.15% 32.30%
Net Working Capital to Revenue		 31.81% 23.98% 25.47% 27.66% 28.93% 28.00% 28.95% 31.90% 31.14% 32.15% 32.30%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.13) ($0.11) ($0.02) $0.13 $0.14 $0.20 $0.12 $0.16 $0.12 $0.05 ($0.01)
Adjusted Weighted Average Basic Shares Outstanding		 108.78M 109.16M 110.18M 113.98M 117.47M 114.76M 116.22M 115.44M 114.80M 115.00M 113.62M
Adjusted Diluted Earnings per Share		 $0.00 ($0.11) $0.00 $0.13 $0.14 $0.00 $0.12 $0.16 $0.12 $0.05 ($0.01)
Adjusted Weighted Average Diluted Shares Outstanding		 110.67M 109.16M 110.54M 114.92M 118.29M 115.83M 116.93M 115.51M 115.45M 115.75M 113.62M
Adjusted Basic & Diluted Earnings per Share		 $0.00 ($0.11) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 110.67M 110.08M 110.54M 121.05M 117.50M 116.38M 115.39M 115.59M 113.56M 113.77M 113.40M
Normalized Net Operating Profit after Tax (NOPAT)		 -0.53 -0.87 7.41 19 17 26 8.44 20 19 8.86 2.41
Normalized NOPAT Margin		 -0.14% -0.21% 1.93% 4.06% 3.97% 5.84% 2.16% 4.64% 4.72% 2.32% 0.66%
Pre Tax Income Margin		 -0.16% 0.24% 2.51% 6.22% 6.32% 7.42% 3.13% 7.56% 6.99% 3.50% 1.41%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 503.32% -85.72% -50.86% -73.11% 60.81% 27.26% 35.27% 40.96% 78.67% 77.56% 136.40%

Financials Breakdown Chart

Key Financial Trends

Here are key trends from Expro Group's quarterly results and balance sheets, focusing on the latest four years of data and highlighting the recent four quarters of 2025.

  • Operating cash flow from continuing activities has remained positive in 2025, with quarterly cash from operating activities (CFO) of about $41.5M (Q1) up to $63.2M (Q3) and $57.1M (Q4), signaling solid cash generation from core operations.
  • Long-term debt declined in 2025, dropping from roughly $121.1M in Q2 to $99.1M by Q3 and persisting at $99.1M in Q4, indicating improved leverage and balance-sheet strength.
  • Free cash flow appears positive in each 2025 quarter (roughly CFO minus capex): approximately $8.4M (Q1), $27.2M (Q2), $39.0M (Q3), and $23.2M (Q4), showing ongoing cash generation after investing activities.
  • Revenue in 2025 stayed robust within a defined band, with quarterly operating revenue around $391M (Q1), $423M (Q2), $411M (Q3), and $382M (Q4), indicating relative revenue stability despite quarter-to-quarter fluctuation.
  • Gross margin has remained roughly in the mid-20s percent (about 25%), suggesting a stable margin profile before operating expenses across 2024–2025.
  • The balance sheet shows a large asset base (~$2.3B) and equity (~$1.5B) with goodwill and intangible assets growing, pointing to asset base expansion while keeping positive equity levels.
  • Net income in Q4 2025 was about $5.8M with EPS of $0.05, a material drop from 2024's corresponding period, signaling a recent profitability headwind in the most recent quarter.
  • Cumulative retained earnings remained negative (approximately -$513M at 2025 Q4), reflecting ongoing losses and a continued drag on book equity from prior periods.
  • Capital expenditures remain elevated in 2025, with quarterly PPE purchases around $21–$34M, meaning ongoing sizable cash outlays for growth and capacity, which pressures near-term liquidity.
  • Quarterly net change in cash in Q4 2025 was slightly negative (~-$1.15M), despite positive CFO, indicating a small quarter-end cash outflow and a need to watch near-term liquidity.
05/14/26 01:55 PM ETAI Generated. May Contain Errors.

Expro Group Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Expro Group's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Expro Group's net income appears to be on a downward trend, with a most recent value of $51.69 million in 2025, falling from $106.11 million in 2015. The previous period was $51.92 million in 2024. Check out Expro Group's forecast to explore projected trends and price targets.

Expro Group's total operating income in 2025 was $81.14 million, based on the following breakdown:
  • Total Gross Profit: $383.92 million
  • Total Operating Expenses: $302.78 million

Over the last 10 years, Expro Group's total revenue changed from $974.60 million in 2015 to $1.61 billion in 2025, a change of 64.9%.

Expro Group's total liabilities were at $725.31 million at the end of 2025, a 13.9% decrease from 2024, and a 164.0% increase since 2015.

In the past 10 years, Expro Group's cash and equivalents has ranged from $116.92 million in 2020 to $602.36 million in 2015, and is currently $196.09 million as of their latest financial filing in 2025.

Over the last 10 years, Expro Group's book value per share changed from 7.81 in 2015 to 13.51 in 2025, a change of 73.0%.


Related Companies

Financial statements for NYSE:XPRO last updated on 5/7/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
You'll buy SpaceX at $1.75 trillion. Insiders bought at $20 billion.
Insiders bought SpaceX at $20 billion. Banks got in at $100 billion. By the time it hits your brokerage accoun...
Behind the Markets | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
NNVC FDA = New Momentum Wave!
NanoViricides (NYSE: NNVC) just received FDA Orphan Drug Designation for its antiviral NV-387, targeting measl...
Equiscreen | Sponsoredtc pixel
Peptide Company Lands Exclusive MMA Wellness Partnership
A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform t...
The Tomorrow Investor | Sponsoredtc pixel
Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...
Weiss Ratings | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
Microscopic Footage Shows Immune Cells Attacking Cancer
Early human trial data from one NASDAQ-listed biotech showed up to a 63.7% reduction in cancer burden using it...
Market Tactic | Sponsoredtc pixel